Vanda Pharmaceuticals Inc (VNDA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.25B
EV to revenue ratio (TTM)
0.49
EV to ebitda
0.76
Financial Performance
Revenue (TTM)
$0.23B
Gross profit (TTM)
$0.21B
EBITDA
-$0.17B
Profitability
Operating margin (TTM)
-33.70%
Profit margin
-119.90%
Return on assets (TTM)
-22.60%
Return on equity (TTM)
-82.60%
Per Share Metrics
Revenue per share (TTM)
$3.83
EPS
-$4.62
Diluted EPS (TTM)
-$4.62
Book value
$3.31
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
103.09
PEG ratio
2.23
Price to sales ratio (TTM)
1.08
Price to book ratio (TTM)
1.15
Growth
Quarterly earnings growth (YoY)
24.10%
Quarterly revenue growth (YoY)
-95.90%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.73